These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27225032)

  • 1. Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.
    Johnson BW; Murray V; Temple MD
    BMC Cancer; 2016 May; 16():333. PubMed ID: 27225032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interactions of novel mononuclear platinum-based complexes with DNA.
    Johnson BW; Burgess MW; Murray V; Aldrich-Wright JR; Temple MD
    BMC Cancer; 2018 Dec; 18(1):1284. PubMed ID: 30577821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
    Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
    Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
    Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
    Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
    Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
    Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
    Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
    Kasparkova J; Farrell N; Brabec V
    J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstrand cross-links of cisplatin induce striking distortions in DNA.
    Malinge JM; Giraud-Panis MJ; Leng M
    J Inorg Biochem; 1999 Oct; 77(1-2):23-9. PubMed ID: 10626349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
    Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
    Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes.
    Zou Y; Van Houten B; Farrell N
    Biochemistry; 1994 May; 33(18):5404-10. PubMed ID: 8180163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA interactions of new antitumor aminophosphine platinum(II) complexes.
    Neplechová K; Kaspárková J; Vrána O; Nováková O; Habtemariam A; Watchman B; Sadler PJ; Brabec V
    Mol Pharmacol; 1999 Jul; 56(1):20-30. PubMed ID: 10385680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
    Kasparkova J; Vrana O; Farrell N; Brabec V
    J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of polynuclear platinum anti-cancer agents.
    Roberts JD; Peroutka J; Farrell N
    J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.
    Muchova T; Quintal SM; Farrell NP; Brabec V; Kasparkova J
    J Biol Inorg Chem; 2012 Feb; 17(2):239-45. PubMed ID: 21938443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of novel bis(platinum) complexes with DNA.
    Roberts JD; Van Houten B; Qu Y; Farrell NP
    Nucleic Acids Res; 1989 Dec; 17(23):9719-33. PubMed ID: 2690006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J; Vojtiskova M; Natile G; Brabec V
    Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
    Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
    J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyrazole ligands.
    Ciesielska E; Szulawska A; Studzian K; Ochocki J; Malinowska K; Kik K; Szmigiero L
    J Inorg Biochem; 2006 Oct; 100(10):1579-85. PubMed ID: 16842854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats.
    Nguyen HT; Galea AM; Murray V
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1041-5. PubMed ID: 23302441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.